https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / BioDrugs 2008;22(2):71-84
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / BioDrugs 2008;22(2):71-842008-01-01 00:00:002019-02-15 09:24:01Prostate cancer vaccines: current status and future potential
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / Anticancer Res. 2008 Jan-Feb;28(1B):379-87
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / Anticancer Res. 2008 Jan-Feb;28(1B):379-872008-01-01 00:00:002019-02-15 09:23:44Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / Recent Results Cancer Res. 2008;177:165-77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / Recent Results Cancer Res. 2008;177:165-772008-01-01 00:00:002019-02-15 09:23:44Immunotherapeutic approaches in pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / Methods Mol. Biol. 2008;423:139-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / Methods Mol. Biol. 2008;423:139-532008-01-01 00:00:002019-02-15 08:48:15Delivery of whole tumor lysate into dendritic cells for cancer vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-21 / J. Leukoc. Biol. 2008 Mar;83(3):742-54
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-21 / J. Leukoc. Biol. 2008 Mar;83(3):742-542007-12-21 00:00:002019-02-15 08:44:35Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-21 / Urol. Oncol. 2008 Jul-Aug;26(4):438-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-21 / Urol. Oncol. 2008 Jul-Aug;26(4):438-442007-12-21 00:00:002019-02-15 09:24:00Immunotherapy for metastatic prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-19 / J Transl Med 2007 Dec;5:67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-19 / J Transl Med 2007 Dec;5:672007-12-19 00:00:002019-02-15 08:59:44Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-05 / J Virol 2008 Feb;82(4):1968-79
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-05 / J Virol 2008 Feb;82(4):1968-792007-12-05 00:00:002023-01-23 10:33:37Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-03 / Immunol. Lett. 2008 Feb;116(1):24-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-03 / Immunol. Lett. 2008 Feb;116(1):24-322007-12-03 00:00:002019-02-15 08:38:06Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-01 / Int J Hyperthermia 2007 Dec;23(8):623-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-01 / Int J Hyperthermia 2007 Dec;23(8):623-432007-12-01 00:00:002019-02-15 08:35:22RF-power and temperature data analysis of 444 patients with primary cervical cancer: deep hyperthermia using the Sigma-60 applicator is reproducible
